Actavis Earnings On Tap After 3 Other IBD 50 Stocks

By | May 9, 2015

Scalper1 News

Earnings season is winding down, but there are still top stocks due to report, including drug giant Actavis (ACT), one of several drug stocks reporting earnings that day, including Intrexon (XON), Impax Laboratories (IPXL) and Juno Therapeutics (JUNO). Actavis is on the IBD 50 list of the very best stocks. Three other IBD 50 stocks — Regeneron Pharmaceuticals (REGN), Monster Beverage (MNST) and Autohome (ATHM) dished out results in the latest Scalper1 News

Scalper1 News